OAKLAND -- Kaiser Permanente received $7.3 million to expand its cancer clinical trials program and to conduct patient care research.
The five-year grant is part of the National Cancer Institute's Community Oncology Research Program, which sponsors cancer clinical trials and care delivery research in patients' own communities, thus generating a broadly applicable evidence base.
Being one of the institute's 34 community-based cancer research sites will help Kaiser continue its focus on "enrolling patients in the NCI Clinical Trials Network, testing new cutting-edge therapies and comparing existing cancer treatments on a patient-by-patient basis," said Dr. Louis Fehrenbacher, director of Kaiser Permanente Northern California's Oncology Clinical Trials.
Kaiser as a community-based cancer research site will serve about one out of every 40 cancer patients in the U.S. The award includes clinical trial programs in Kaiser's Northern California, Southern California, Northwest, Colorado and Hawaii regions.
The designation also provides funding for research into cancer care delivery.
"Kaiser Permanente is ideally situated to be a major force and provide national leadership in cancer care delivery research," said Laurel A. Habel, who will co-lead the new research program. "The investigators in our research centers are experienced in delivery-care science and multi-institutional studies, have access to cancer registries and research databases and, most importantly, are committed to improving cancer care delivery and outcomes."